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Key findings
Data from the National Vital 
Statistics System Mortality 
File
• From 1999 through 2006, 
the number of fatal poisonings 
involving opioid analgesics 
more than tripled from 4,000 
to 13,800 deaths.
• Opioid analgesics were 
involved in almost 40% of all 
poisoning deaths in 2006.
• In 2006, the rate of 
poisoning deaths involving 
opioid analgesics was higher 
for males, persons aged 35-54 
years, and non-Hispanic white 
persons than for females and 
those in other age and racial/ 
ethnic groups.
• In about one-half of the 
deaths involving opioid 
analgesics, more than one 
type of drug was specified as 
contributing to the death, with 
benzodiazepines specified 
with opioid analgesics most 
frequently.
• The age-adjusted death rate 
for poisoning involving opioid 
analgesics varied more than 
eightfold among the states in
2006.
Poisoning is the second leading cause of injury death overall, and the leading 
cause of injury death for people aged 35-54 years, surpassing both firearm- 
related and motor vehicle-related deaths in this age group (1,2). During the 
Healthy People 2010 midcourse review, reduction of poisoning mortality was 
one of the injury objectives identified as moving away from its target. One 
of the challenges discussed during the review is a lack of recognition of the 
extent of the problem.
Drug poisonings are the largest portion of the poisoning burden and opioid 
analgesic-related deaths (see “Definitions” section) are among the fastest 
increasing drug poisoning deaths (3,4). This report highlights trends in fatal 
opioid analgesic-related poisonings from the years 1999-2006.
Keywords: National Vital Statistics System Mortality File • methadone • 
drugs • overdose
The number of poisoning deaths and the percentage of 
these deaths involving opioid analgesics increased each 
year from 1999 through 2006.
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From 1999 through 2006, the number of poisoning deaths nearly doubled from almost 20,000 to 
more than 37,000 (Figure 1). In 2006, over 90% of poisoning deaths involved drugs.
Opioid analgesics were involved in almost 40% of all poisoning deaths in 2006, up from about 
20% in 1999. The death records for about one-fifth of poisoning deaths each year indicated drug 
involvement, but did not specify the substance involved; an unknown proportion of these deaths 
involved opioid analgesics.
From 1999 through 2006, poisoning deaths involving methadone rose more 
rapidly than those involving other opioid analgesics, cocaine, or heroin.
NOTES: Drug categories are not m utua lly exclusive. Deaths involving more than one drug category shown in th is  figure  are  counted m ultip le times. Access data 
tab le  fo r F igure 2 a t ftp ://ftp .cdc.gov/pub/Health_S tatistics/NC HS/Publications/Data_Brie fs/db022/fig02.xls.
SOURCE: CDC/NCHS, National Vital S ta tistics System.
The number of poisoning deaths involving methadone increased nearly sevenfold from almost 
790 in 1999 to almost 5,420 in 2006, which is the most rapid increase among opioid analgesics 
and other narcotics involved in poisoning deaths (Figure 2) . Between 2005 and 2006, the number 
of poisoning deaths involving other synthetic narcotics increased by more than 50%. This 
increase may be related to the illicit manufacture of nonpharmaceutical fentanyl in 2006 (5).
Throughout the period 1999-2006, people aged 35-54 years had higher 
poisoning death rates involving opioid analgesics than those in other age 
groups.
From 1999 to 2006, poisoning death rates involving opioid analgesics increased for every age 
group from 15-24 years through 65 years and older, males and females, and non-Hispanic white 
and non-Hispanic black persons (Appendix table).
Increases among age groups ranged from about twofold (65 years and over) to more than fivefold 
(15-24 years) (Figure 3). Males had higher age-adjusted poisoning death rates involving opioid 
analgesics than females throughout the period. In 2006, the rate for males was about 75% higher 
than for females. In 2006, the age-adjusted death rate for poisoning involving opioid analgesics 
among non-Hispanic white persons was about twice that of non-Hispanic black persons and 
almost three times that of Hispanic persons.
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Figure 3. Death rates for poisonings involving opioid analgesics, by age: United States, 1999-2006
Year
SOURCE: CDC/NCHS, National Vital S ta tistics System.
More than one type of drug was mentioned in the majority of poisoning 
deaths that involved opioid analgesics in 2006.
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SOURCE: CDC/NCHS, National V ital S ta tistics System.
About one-third of opioid analgesic-related poisoning deaths involved no other drugs and 16% 
involved nonspecified drug(s) (Figure 4). Deaths with a nonspecified drug could potentially 
involve only opioid analgesics. About one-half of opioid analgesic-related deaths involved at least 
one other drug that was specified on the death certificate; benzodiazepines were involved in 17% 
of the deaths, cocaine or heroin in 15%, and benzodiazepines with cocaine or heroin in 3%.
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Death rates for poisoning involving opioid analgesics varied more than 
eightfold among the states in 2006.
Figure 5. Age-adjusted death rates for poisonings involving opioid analgesics: Comparison o fsta te  and U.S. rates: 
United States, 2006
■  Rate significantly higher than U.S. rate □  Rate not significantly different than U.S. rate
□  Rate significantly lowerthan U.S. rate □  Rate is based on few erthan 20 deaths and is
considered unreliable
NOTE: Access data tab le  fo r F igure 5 a t ftp ://ftp .cdc.gov/pub/Health_S tatistics/NC HS/Publications/Data_Brie fs/db022/fig05.xls.
SOURCE: CDC/NCHS, National Vital S ta tistics System.
In 2006, age-adjusted death rates for poisoning deaths involving opioid analgesics ranged from
1.8 to 15.6 deaths per 100,000 population among the states. In 16 states, the rate was statistically 
significantly higher than the U.S. rate of 4.6 deaths per 100,000 (Figure 5) .
In 2006, West Virginia, Utah, New Mexico, Oklahoma, and Nevada had the five highest rates, 
ranging from 10.5 to 15.6 per 100,000. State-specific comparisons should be interpreted with 
caution as there is some variation in the reporting of substances on death records.
Summary
Opioid analgesics are drugs that are usually prescribed to treat pain. Poisoning death rates 
involving opioid analgesics have more than tripled in the United States since 1999. Among 
opioid analgesic-related deaths, those involving methadone increased the most during the period 
1999-2006.
Methadone is a long-acting opioid and requires a complex dosing schedule. Methadone relieves 
pain for 4 to 8 hours, but remains in the body for up to 59 hours (6) . A lack of knowledge about 
the unique properties of methadone was identified as contributing to some deaths (6).
Knowing whether other drugs are involved with opioid analgesics in poisoning deaths helps in 
developing prevention strategies. The data suggest that multiple drugs were involved in at least 
one-half of the opioid analgesic-related deaths. The involvement of benzodiazepines—sedatives 
used to treat anxiety, insomnia, and seizures—is particularly troubling as previous studies have 
shown that people who were prescribed both methadone and benzodiazepine were at greater risk 
of overdose than those prescribed only one of these drugs (7).
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State variation in opioid analgesic-related death rates provides an opportunity to study factors 
associated with deaths involving opioid analgesics. States vary widely in their prescription and 
other drug policies (8) . For instance, 32 states have operational drug monitoring programs with 
statewide databases that monitor the prescribing and dispensing of prescription drugs (9) .
Opioid analgesics have abuse potential and are, therefore, a controlled substance under the U.S. 
Drug Enforcement Administration (DEA). Recent studies have shown a rise in distribution and 
prescription of opioids (10,11,12) . It could not be determined from death certificates whether the 
opioid analgesics involved in poisoning deaths were prescribed for the decedent or obtained in 
another way. Several regional studies have shown that at least some decedents obtained opioid 
analgesics illegally (6,11).
Several government agencies are taking action on opioid analgesic-related poisonings including 
CDC, DEA, the National Institute on Drug Abuse, the Office of National Drug Control Policy, 
the Substance Abuse and Mental Health Services Administration, and the U.S. Food and Drug 
Administration.
The importance of opioid analgesics in the management of pain is unquestioned. However, 
increasing opioid analgesic-related poisoning deaths pose a serious public health risk.
Definitions
Narcotic refers to both opioid analgesics and illicit drugs including opium, heroin, and cocaine.
Opioid analgesics are drugs that are usually prescribed to relieve pain and include: methadone, 
which is used to treat opioid dependency as well as pain; other opioids, such as oxycodone and 
hydrocodone; and synthetic narcotics such as fentanyl and propoxyphene. Opium, heroin, and 
cocaine are not included in this class.
Poisoning deaths include those resulting from accidental or intentional overdoses of a drug, being 
given the wrong drug, taking the wrong drug in error, or taking a drug inadvertently. Poisoning 
deaths also include those involving biological or other toxic substances, gases, or vapors.
Data sources and methods
Estimates are based on the National Vital Statistics System multiple cause of death mortality 
files (13). Poisoning deaths were defined as those with an underlying cause of death classified to 
the International Classification o f Diseases, Tenth Revision (ICD-10) external cause of injury 
codes X40-X49, X60-X69, X85-X90, Y10-Y19, Y35.2, or *U01(.6-.7) (14). Estimates are 
for poisoning deaths of any intent (unintentional, suicide, homicide or legal intervention, or 
undetermined) for U.S. residents.
Among deaths with poisoning as the underlying cause, the following ICD-10 codes indicate 
whether and the type of drug(s) involved: no drug (none of the codes T36-T50.9); drug(s) (any of 
the codes T36-T50.9); only nonspecified drug(s) (only T50.9); specified drug(s) other than opioid 
analgesic (any of the codes T36-T50.8 other than T40.2-T40.4); any opioid analgesic (any of the 
codes T40.2-T40.4); other opioid (T40.2); methadone (T40.3); other synthetic narcotic (T40.4); 
heroin (T40.1); cocaine (T40.5); and benzodiazepine (T42.4).
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Age-adjusted death rates were calculated using the direct method and the 2000 standard 
population. To identify state rates that were significantly higher or lower than the overall U.S. 
rate, differences between national and state estimates were evaluated using two-sided significance 
tests at the 0.01 level.
Several factors related to death investigation and reporting may affect measurement of death 
rates involving specific drugs. At autopsy, toxicological lab tests may be performed to determine 
the type of legal and illegal drugs present. The substances tested for and circumstances in which 
the tests are performed vary by jurisdiction. Increased attention to fatal poisonings associated 
with prescription pain medication may have led to changes in reporting practices over time such 
as increasing the level of substance specific detail included on the death certificates. Substance 
specific death rates are more susceptible to measurement error related to these factors than the 
overall poisoning death rate.
Appendix table. Number of deaths and death rates for poisoning involving opioid analgesics, by demographic 




1999 2000 2001 2002 2003 2004 2005 2006 19991 2005
Number of deaths
Total 4,041 4,419 5,538 7,475 8,535 9,876 10,947 13,755 3.4 1.3
Deaths per 100,000 population
to ta l2 1.4 1.6 1.9 2.6 2.9 3.4 3.7 4.6 3.3 1.2
Age
Under 15 years 'k 0.0 0.0 0.1 0.1 0.1 0.1 0.1 'k 1.0
15-24 years 0.7 0.8 1.3 1.7 2.2 2.7 2.8 3.8 5.4 1.4
25-34  years 1.9 1.9 2.3 3.3 3.7 4.4 5.2 6.7 3.5 1.3
35-44  years 3.5 3.7 4.5 5.7 6.2 6.8 6.9 8.3 2.4 1.2
45-54  years 2.9 3.3 4.0 5.5 6.2 7.1 8.0 9.7 3.3 1.2
55-64  years 1.0 1.1 1.4 1.8 2.2 2.6 3.1 4.0 4.0 1.3
65 years and over 0.4 0.3 0.4 0.6 0.6 0.7 0.8 0.9 2.3 1.1
Sex2
Male 2.0 2.1 2.5 3.3 3.7 4.2 4.5 5.8 2.9 1.3
Female 0.9 1.1 1.4 1.9 2.1 2.5 2.8 3.3 3.7 1.2
Race and Hispanic origin2
Hispanic 1.7 1.2 1.2 1.5 1.6 1.5 1.6 2.0 1.2 1.3
Non-Hispanic white 1.6 1.8 2.4 3.2 3.7 4.3 4.7 5.8 3.6 1.2
Non-hispanic black 0.9 0.9 1.1 1.3 1.3 1.5 1.8 2.7 3.0 1.5
* Figure does not meet standards of reliability or precision. Rate is based on fewer than 20 deaths and is considered 
unreliable.
0.0 Quantity more than zero but less than 0.05.
’ Interpret the ratio of 2006 to 1999 for the total number of deaths as follows: the number of deaths in 2006 was 3.4
times the number in 1999.
2Age-adjusted death rates were calculated using the direct method and the 2000 standard population.
NOTES: Poisoning deaths involving opioid analgesics are deaths classified with an International Classification of 
Diseases, Tenth Revision code o f X40-X49, X60-X69, X85-X90, Y10-Y19, Y35.2, or *U 01(.6-.7) as an underlying 
cause of death and any mention o f T40.2, T40.3, or T40.4 as a multiple cause. Opioid analgesics are drugs that are 
generally used to relieve pain, (see “Definitions” section) .
SOURCE: CDC/NCHS, National Vital Statistics System.
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